On November 2, 2026 Olema Pharmaceuticals, Inc. ("Olema" or "Olema Oncology", Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, reported that the Company will participate in the following upcoming investor conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Guggenheim 3rd Annual Healthcare Innovation Conference
Date and Time: November 10, 2026 at 10 a.m. ET
Format: Fireside Chat
Location: Boston, MA
Stifel 2026 Healthcare Conference
Date and Time: November 11, 2026 at 10:40 a.m. ET
Format: Fireside Chat
Location: New York, NY
UBS Global Biopharma Conference
Date and Time: November 17, 2026 at 3:20 p.m. GMT/10:20 a.m. ET
Format: Fireside Chat
Location: London, England
Jefferies Global Healthcare Conference
Date and Time: November 18, 2026 at 4 p.m. GMT/11 a.m. ET
Format: Fireside Chat
Location: London, England
Live webcasts and recordings of these presentations will be available, as permitted by the event host, in the Events and Presentations section of Olema’s investor relations website at ir.olema.com.
(Press release, Olema Oncology, NOV 2, 2026, View Source [SID1234674063])